Myoclonus Dystonia Syndrome among the Pediatric Population: A Case Report

Main Article Content

Konika Bansal

Abstract

Myoclonus-dystonia syndrome (MDS) is a rare movement disorder of the central nervous system. It is primarily characterized by myoclonus and may be associated with dystonia. MDS usually occurs in the early to 20s stage of life. Although the disease has a mild course, but can lead to functional disability in some minority of patients. In this paper, we present a probable case diagnosis of MDS based on the clinical characteristics. The patient presented significant improvement with topiramate and anti-dystonic treatment.

Article Details

How to Cite
Bansal, K. (2023). Myoclonus Dystonia Syndrome among the Pediatric Population: A Case Report. Journal of Comprehensive Clinical Practice, 17(2), 53–55. Retrieved from https://9vom.in/journals/index.php/jocp/article/view/115
Section
Case Reports

References

Kinugawa, K., Vidailhet, M., Clot, F., Apartis, E., Grabli, D., & Roze, E. (2009). Myoclonus‐dystonia: an update. Movement Disorders, 24(4), 479-489.

Raymond, D., Saunders-Pullman, R., & Ozelius, L. (2020). SGCE myoclonus-dystonia.

Roze, E., Lang, A. E., & Vidailhet, M. (2018). Myoclonusdystonia: classification, phenomenology, pathogenesis, and treatment. Current Opinion in Neurology, 31(4). 484-490.

Grünewald, A., Djarmati, A., Lohmann‐Hedrich, K., Farrell, K., Zeller, J. A., Allert, N., ... & Klein, C. (2008). Myoclonusdystonia: significance of large SGCE deletions. Human mutation, 29(2), 331-332.

Kosutzka, Z., Tisch, S., Bonnet, C., Ruiz, M., Hainque, E., Welter, M. L., ... & Vidailhet, M. (2019). Long‐term GPi‐DBS improves motor features in myoclonus‐dystonia and enhances social adjustment. Movement Disorders, 34(1), 87-94.